Evidence map›Paper›PMID 42415086›Full record

ArticleCardiovascular diabetology2026

Association of C-reactive protein-triglyceride glucose index and its modified indices with stroke risk in individuals at cardiovascular-kidney-metabolic syndrome stages 0-3: a population-based cohort study.

Dan Yang, Yan Deng, Zihan Su, Min Zhao

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dan YangNational Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.
Yan DengSchool of Public Health, China Medical University, Shenyang, People's Republic of China.
Zihan SuNational Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.
Min ZhaoNational Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China. minzhao@cmu.edu.cn.

Funding

Ministry of Science and Technology of the People's Republic of China 2022YFC3602302Natural Science Foundation of Liaoning Province 2024-BSLH-339
6 · The paper itself

Abstract

backgroundStroke pathogenesis in Cardiovascular-Kidney-Metabolic (CKM) is driven by a complex interplay of insulin resistance (IR), systemic inflammation, and adiposity. This study investigated whether integrating adiposity-related measures with the inflammation-IR axis could refine stroke risk prediction in individuals at CKM stage 0-3.

methodsA total of 3,348 participants (aged ≥ 45) at CKM stages 0-3 were included from the China Health and Retirement Longitudinal Study (CHARLS). Baseline levels, cumulative exposures, and longitudinal changes were assessed for the original C-reactive protein-triglyceride glucose index (CTI) and seven adiposity-modified CTI indices. Associations with stroke risk were evaluated using Cox proportional hazards models, and potential non-linear relationships were examined using restricted cubic splines. Predictive performance at 3 and 5 years was assessed using fixed-horizon receiver operating characteristic (ROC) analysis. Discrimination was quantified by the area under the curve (AUC) and compared using DeLong's test, while incremental predictive value was further evaluated using the integrated discrimination improvement (IDI) index. Mediation analysis was used to evaluate the potential role of estimated pulse wave velocity (ePWV) in these associations. Subgroup and sensitivity analyses were conducted to test result robustness, and weighted quantile sum (WQS) regression was performed to determine the relative contribution of components within CTI-related indices.

resultsDuring follow-up, 263 new cases of stroke were observed (7.9%). In fully adjusted models, participants in the highest tertile of all CTI-related indices had significantly increased stroke risk, with hazard ratios (HRs) ranging from 1.92 (95%CI 1.35-2.73) for original CTI to 2.52 (95%CI 1.76-3.61) for CTI-WHtR. K-means clustering of longitudinal changes identified three trajectory groups; compared with the stable group, both markedly increasing and slowly increasing trajectories of CTI and its modified indices were significantly associated with higher stroke risk. In fixed-horizon ROC analyses, the 3-year AUCs for all indices exceeded 0.70. Among baseline indices, CTI-BRI, CTI-BMI, CTI-WC, and CTI-WHtR showed significantly higher AUCs than the original CTI, whereas only CTI-BMI demonstrated a small but significant improvement in IDI over CTI (IDI = 0.0021, 95% CI 0.0004-0.0038; P = 0.012). Among cumulative indices, cumCTI-BMI and cumCTI-WHtR showed significantly higher 3-year AUCs than cumCTI. CTIs-stroke associations were stronger in advanced CKM stages (2-3). Furthermore, component analysis identified CVAI (29.0% in 2012; 29.3% in 2015) as the primary driver of predictive power. ePWV partially mediated the associations between CTI-related indices and incident stroke, with mediation proportions of 12.44%-21.20%.

conclusionsCTI and adiposity-modified CTI indices were independently associated with incident stroke among adults at CKM stages 0-3, especially in advanced CKM stages. Incorporating adiposity-related information provided modest and inconsistent improvement in short-term prediction, with CVAI contributing most prominently and ePWV suggesting a potential arterial stiffness pathway. These findings support the relevance of combined inflammatory, IR, and adiposity burden in stroke risk assessment, but the clinical use of complex composite indices should be balanced against screening feasibility.

Indexed as

Blood GlucoseC-Reactive ProteinInflammation MediatorsKidney DiseasesMetabolic SyndromeStrokeTriglyceridesAdiposityAgedBiomarkersChinaFemaleHumansInsulin ResistanceLongitudinal StudiesMaleBiomarkersBlood GlucoseC-Reactive ProteinInflammation MediatorsTriglyceridesCardiovascular-kidney-metabolic syndromeCHARLSC-reactive protein-triglyceride glucose indexObesity-related measuresStroke

Identifiers

PMID42415086
PMCPMC13491843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.